|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.62 CNY | -0.21% |
|
+4.43% | -4.66% |
| 06-09 | China Approves Aodong Subsidiary's Levocarnitine Injection | MT |
| 05-21 | Jilin Aodong Pharmaceutical Gets China Approval for Supplemental Registration of Heart Drug | MT |
| Market Cap | 21.83B 3.22B 2.82B 2.61B 2.39B 4.52B 311B 4.6B 31.07B 12.2B 152B 12.1B 11.84B 524B | P/E 2024 |
13.1x | P/E 2025 | 9.57x |
|---|---|---|---|---|---|
| Enterprise Value | 21.11B 3.12B 2.72B 2.52B 2.31B 4.37B 300B 4.45B 30.04B 11.8B 147B 11.7B 11.44B 506B | EV / Sales 2024 |
7.76x | EV / Sales 2025 | 9.49x |
| Free-Float |
67.59% | Yield 2024 |
2.9% | Yield 2025 | 2.56% |
| 1 day | -0.21% | ||
| 1 week | +4.43% | ||
| Current month | +5.02% | ||
| 1 month | +4.14% | ||
| 3 months | +1.25% | ||
| 6 months | -7.32% | ||
| Current year | -4.66% |
| 1 week | 17.27 | 18.77 | |
| 1 month | 17.08 | 18.88 | |
| Current year | 16.36 | 20.93 | |
| 1 year | 16.36 | 22.08 | |
| 3 years | 12.49 | 22.08 | |
| 5 years | 12.49 | 22.08 | |
| 10 years | 12.49 | 29.43 |
| Manager | Title | Age | Since |
|---|---|---|---|
Shu Qin Guo
CEO | Chief Executive Officer | 63 | 2017-07-16 |
Kai Yang
DFI | Director of Finance/CFO | 49 | 2004-04-30 |
Shu Yuan Zhang
DFI | Director of Finance/CFO | 54 | 2007-06-17 |
| Director | Title | Age | Since |
|---|---|---|---|
Shu Qin Guo
BRD | Director/Board Member | 63 | 2000-01-31 |
Yu Ju Sun
BRD | Director/Board Member | 54 | 2008-05-05 |
Shu Yuan Zhang
BRD | Director/Board Member | 54 | 2020-07-16 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 11/25/25 | Buy | 100 | 0.0000% | |||
| 7/29/24 | Buy | Chairman | 350,000 | 0.0302% | ||
| 7/29/24 | Buy | Chief Executive Officer | 320,000 | 0.0276% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.21% | +4.43% | +2.65% | +15.01% | 3.22B | ||
| +1.08% | -3.93% | +48.03% | +160.13% | 1,043B | ||
| +1.19% | -3.52% | +51.70% | +56.36% | 602B | ||
| +4.21% | +1.79% | +33.48% | +87.04% | 449B | ||
| +0.06% | -1.49% | +29.03% | +23.64% | 327B | ||
| +0.88% | +0.05% | +33.21% | +46.42% | 279B | ||
| -0.65% | -2.38% | +21.49% | +22.82% | 264B | ||
| +3.70% | +2.19% | +24.27% | +63.38% | 201B | ||
| +3.49% | +1.08% | +24.08% | +76.58% | 169B | ||
| +1.29% | +3.67% | +2.15% | -30.78% | 143B | ||
| Average | +1.24% | -0.06% | +27.01% | +52.06% | 348.03B | |
| Weighted average by Cap. | +1.55% | -1.81% | +37.33% | +82.75% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.61B 385M 337M 312M 286M 541M 37.14B 550M 3.72B 1.46B 18.13B 1.45B 1.42B 62.61B | 2.34B 345M 301M 279M 256M 484M 33.22B 492M 3.32B 1.31B 16.22B 1.29B 1.27B 56B |
| Net income | 1.55B 229M 200M 185M 170M 322M 22.07B 327M 2.21B 867M 10.78B 860M 841M 37.21B | 2.4B 354M 309M 286M 262M 496M 34.07B 505M 3.41B 1.34B 16.64B 1.33B 1.3B 57.44B |
| Net Debt | -386M -56.98M -49.8M -46.06M -42.27M -79.99M -5.49B -81.38M -549M -216M -2.68B -214M -209M -9.26B | -724M -107M -93.42M -86.4M -79.28M -150M -10.3B -153M -1.03B -405M -5.03B -401M -393M -17.36B |
Employees
5,461
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-16 | CN¥18.62 | -0.21% | 20,506,958 |
| 26-07-15 | CN¥18.66 | +4.30% | 27,751,556 |
| 26-07-14 | CN¥17.89 | +2.23% | 15,633,702 |
| 26-07-13 | CN¥17.50 | -0.79% | 12,861,097 |
| 26-07-10 | CN¥17.64 | -1.07% | 14,006,300 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 000623 Stock
Select your edition
All financial news and data tailored to specific country editions
















